TABLE 4.
Assay | Performance (%) |
||||
---|---|---|---|---|---|
Sensitivityc | Specificityd | PPV | NPV | Concordance with ISAGA-M | |
AdviaCentaure | 89.4 | 98.1 | 85.7 | 98.6 | 81 |
Architecte | 80.9 | 99.7 | 97.4 | 97.6 | 95.2 |
AxSYMf | 86 | 100 | 100 | 97.9 | 60 |
Elecsyse | 76.6 | 96.7 | 75 | 97 | 92.9 |
Enzygnoste | 84.2 | 99.7 | 97 | 98.4 | 16.7 |
Liaisone | 61.7 | 98.4 | 82.4 | 95.3 | 59.5 |
Plateliae | 97.9 | 92.6 | 63 | 99.7 | 97.6 |
VIDASf | 65 | 99.7 | 90.5 | 94.9 | 70 |
VIDIAf | 79 | 97.9 | 90.5 | 94.3 | 60 |
Panels containing 419 serum samples in assessment 1 and 406 serum samples in assessment 2.
Panels containing 19 serum samples in assessment 1 and 45 serum samples in assessment 2.
Sensitivity = true positive/(true positive + false negative).
Specificity = true negative/(true negative + false positive).
Assessment 2.
Assessment 1.